An MRI-histological study of white matter in stroke-free SHRSP

Journal of Cerebral Blood Flow and Metabolism

Volumn 33, Issue 5, 2013, Pages 760-763

  Brittain, John F ^a   McCabe, Christopher ^b   Khatun, Halima ^a   Kaushal, Nitika ^a   Bridges, Leslie R ^c   Holmes, William M ^b   Barrick, Thomas R ^a   Graham, Delyth ^d   Dominiczak, Anna F ^d   Mhairi MacRae, I ^b   Hainsworth, Atticus H ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c ST GEORGE'S UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

experimental; hypertension; immunohistochemistry; magnetic resonance; neuropathology; white matter disease

Indexed keywords

SMOOTH MUSCLE ACTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTICLE; CAUDATE NUCLEUS; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DIFFUSION TENSOR IMAGING; HISTOPATHOLOGY; MALE; MORPHOMETRICS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; STROKE PRONE SPONTANEOUSLY HYPERTENSIVE RAT; WHITE MATTER;

ANIMALS; BRAIN; CEREBRAL ARTERIES; HYPERTENSION; LEUKOENCEPHALOPATHIES; MALE; MYELIN BASIC PROTEIN; RATS; RATS, INBRED SHR; STROKE;

EID: 84877579262     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2013.14     Document Type: Article

References (26)

1. Fazekas F, Kleinert R, Offenbacher H, Schmidt R, Kleinert G, Payer F et al. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology 1993; 43: 1683-1689.
2. Schmidt R, Schmidt H, Haybaeck J, Loitfelder M, Weis S, Cavalieri M et al. Heterogeneity in age-related white matter changes. Acta Neuropathol 2011; 122: 171-185.
3. Fernando MS, Simpson JE, Matthews F, Brayne C, Lewis CE, Barber R et al. White matter lesions in an unselected cohort of the elderly: molecular pathology suggests origin from chronic hypoperfusion injury. Stroke 2006; 37: 1391-1398.
4. Dufouil C, Chalmers J, Coskun O, Besancon V, Bousser MG, Guillon P et al. Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy. Circulation 2005; 112: 1644-1650.
5. Yamori Y, Horie R, Handa H, Sato M, Fukase M. Pathogenetic similarity of strokes in stroke-prone spontaneously hypertensive rats and humans. Stroke 1976; 7: 46-53.
6. Linz W, Heitsch H, Scholkens BA, Wiemer G. Long-term angiotensin II type 1 receptor blockade with fonsartan doubles lifespan of hypertensive rats. Hypertension 2000; 35: 908-913.
7. Yamori Y, Horie R. Developmental course of hypertension and regional cerebral blood flow in stroke-prone spontaneously hypertensive rats. Stroke 1977; 8: 456-461.
8. Hainsworth AH, Markus HS. Do in vivo experimental models reflect human cerebral small vessel disease A systematic review. J Cereb Blood Flow Metab 2008; 28: 1877-1891.
9. Henning EC, Warach S, Spatz M. Hypertension-induced vascular remodeling contributes to reduced cerebral perfusion and the development of spontaneous stroke in aged SHRSP rats. J Cereb Blood Flow Metab 2010; 30: 827-836.
10. Bailey EL, Smith C, Sudlow CL, Wardlaw JM. Is the spontaneously hypertensive stroke prone rat a pertinent model of sub cortical ischemic stroke A systematic review. Int J Stroke 2011; 6: 434-444.
11. Schreiber S, Bueche CZ, Garz C, Kropf S, Angenstein F, Goldschmidt J et al. The pathologic cascade of cerebrovascular lesions in SHRSP: is erythrocyte accumulation an early phase J Cereb Blood Flow Metab 2012; 32: 278-290.
12. Linz W, Jessen T, Becker RH, Scholkens BA, Wiemer G. Long-term ACE inhibition doubles lifespan of hypertensive rats. Circulation 1997; 96: 3164-3172.
13. Lee DY, Fletcher E, Martinez O, Ortega M, Zozulya N, Kim J et al. Regional pattern of white matter microstructural changes in normal aging, MCI, and AD. Neurology 2009; 73: 1722-1728.
14. O'Sullivan M, Summers PE, Jones DK, Jarosz JM, Williams SC, Markus HS. Normalappearing white matter in ischemic leukoaraiosis: a diffusion tensor MRI study. Neurology 2001; 57: 2307-2310.
15. Guerrini U, Sironi L, Tremoli E, Cimino M, Pollo B, Calvio AM et al. New insights into brain damage in stroke-prone rats: a nuclear magnetic imaging study. Stroke 2002; 33: 825-830.
16. Jalal FY, Yang Y, Thompson J, Lopez AC, Rosenberg GA. Myelin loss associated with neuroinflammation in hypertensive rats. Stroke 2012; 43: 1115-1122.
17. Lin JX, Tomimoto H, Akiguchi I, Wakita H, Shibasaki H, Horie R. White matter lesions and alteration of vascular cell composition in the brain of spontaneously hypertensive rats. Neuroreport 2001; 12: 1835-1839.
18. Dong YF, Kataoka K, Tokutomi Y, Nako H, Nakamura T, Toyama K et al. Beneficial effects of combination of valsartan and amlodipine on salt-induced brain injury in hypertensive rats. J Pharmacol Exp Ther 2011; 339: 358-366.
19. Bradl M, Lassmann H. Oligodendrocytes: biology and pathology. Acta Neuropathol 2010; 119: 37-53.
20. Miron VE, Kuhlmann T, Antel JP. Cells of the oligodendroglial lineage, myelination, and remyelination. Biochim Biophys Acta 2011; 1812: 184-193.
21. Miyamoto N, Tanaka R, Shimura H, Watanabe T, Mori H, Onodera M et al. Phosphodiesterase III inhibition promotes differentiation and survival of oligodendrocyte progenitors and enhances regeneration of ischemic white matter lesions in the adult mammalian brain. J Cereb Blood Flow Metab 2010; 30: 299-310.
22. Baumbach GL, Walmsley JG, Hart MN. Composition and mechanics of cerebral arterioles in hypertensive rats. Am J Pathol 1988; 133: 464-471.
23. Nordborg C, Fredriksson K, Johansson BB. The morphometry of consecutive segments in cerebral arteries of normotensive and spontaneously hypertensive rats. Stroke 1985; 16: 313-320.
24. Hachinski V, Iadecola C, Petersen RC, Breteler MM, Nyenhuis DL, Black SE et al. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke 2006; 37: 2220-2241.
25. Lammie GA, Brannan F, Slattery J, Warlow C. Nonhypertensive cerebral smallvessel disease. An autopsy study. Stroke 1997; 28: 2222-2229.
26. Joutel A, Monet-Lepretre M, Gosele C, Baron-Menguy C, Hammes A, Schmidt S et al. Cerebrovascular dysfunction and microcirculation rarefaction precede white matter lesions in a mouse genetic model of cerebral ischemic small vessel disease. J Clin Invest 2010; 120: 433-445.